Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome

NCT02460328 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT02460328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02460328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome
Lead sponsor
Mahidol University
Phase
Observational
Overall status
Completed
Start date
February 28, 2015
Completion date
February 29, 2016
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

22q11.2 deletion syndrome, immune defect